Inventor
DAVIE REBECCA LOUISE
GB14 patents
⚠️ This page may combine multiple inventors who share the name “DAVIE REBECCA LOUISE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KALVISTA PHARMACEUTICALS LTD
13 patentsUS10611758B2Apr 7, 2020
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD4 citations83
US10364238B2Jul 30, 2019
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD8 citations83
US9670157B2Jun 6, 2017
Benzylamine derivatives
KALVISTA PHARMACEUTICALS LTD13 citations80
US9738641B2Aug 22, 2017
Bicyclic inhibitors
KALVISTA PHARMACEUTICALS LTD13 citations79
US9533987B2Jan 3, 2017
Heterocyclic derivates
KALVISTA PHARMACEUTICALS LTD19 citations79
US10781181B2Sep 22, 2020
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD6 citations72
US9834513B2Dec 5, 2017
Benzylamine derivatives
KALVISTA PHARMACEUTICALS LTD4 citations69
US11198691B2Dec 14, 2021
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11084809B2Aug 10, 2021
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11001578B2May 11, 2021
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11180484B2Nov 23, 2021
Pyrazole derivatives as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations56
US9234000B2Jan 12, 2016
Benzylamine derivatives as inhibitors of plasma kallikrein
KALVISTA PHARMACEUTICALS LTD0 citations50
US11613527B2Mar 28, 2023
Enzyme inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations47